http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104127658-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27ccb0a7cad2c4d8e26f39dae76286a0 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8964 |
filingDate | 2014-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b570c43e13d5139cea53f5298826ba22 |
publicationDate | 2014-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104127658-A |
titleOfInvention | Traditional Chinese medicament for treating motor neuron diseases and preparation method thereof |
abstract | The invention relates to a traditional Chinese medicament for treating motor neuron diseases and a preparation method thereof. The traditional Chinese medicament is prepared from the following medicinal materials in parts by weight: 10-15 parts of rhizoma anemarrhenae, 5-9 parts of radix paeoniae alba, 4-8 parts of licorice root, 10-16 parts of sambucus chinensis, 6-10 parts of herba ecliptae, 11-15 parts of fruticose breyniae leaf and twig, 5-7 parts of eucommia ulmoides, 5-9 parts of fructus psoraleae, 12-15 parts of paraboea dictyoneura, 10-15 parts of duckweed, 11-18 parts of achyranthes bidentata, 5-7 parts of Chinese ginseng, 3-7 parts of lucid ganoderma, 2-6 parts of musk and 5-10 parts of herba epimedii. A preparation process of the traditional Chinese medicament sequentially comprises the steps of roasting, grinding, soaking and concentrating the medicinal materials to prepare tablets, capsules, granules or oral solutions. The traditional Chinese medicament has the characteristics of quick response and high cure rate in treating motor neuron diseases, such as cerebral palsy, mental retardation, Parkinson disease, encephalatrophy, cerebral dysplasia, cerebral hemorrhage sequelae, cerebral trauma sequelae, muscle atrophy, myasthenia and progressive muscular dystrophy. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107233371-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104721536-A |
priorityDate | 2014-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.